O USO DE RISPERIDONA EM CASOS DE AUTISMO INFANTIL: UMA REVISÃO BIBLIOGRÁFICA

Abstract

Autism Spectrum Disorder (ASD) is part of the group of neurodevelopmental disorders, which manifest early, at the beginning of children's development, and can be characterized as deficits in global development. To this end, the present work aims to investigate the prevalence of the use of the atypical antipsychotic, Risperidone, in the treatment of Autism Spectrum Disorder, given that its prevalence has increased in recent years, this increase in ASD may be linked to the expansion of criteria diagnoses and the development of screening instruments, the increase in prevalence is not related to new cases, but rather to better definition in diagnosis and investigation, therefore, ASD is a public health problem. This research is a Bibliographic Review, where the search for articles was carried out on the Google Scholar search platform, thus, 9 articles were selected for the production of the bibliographic review. From the results found in this research, we can conclude that Risperidone, in all research, was the most prevalent, cited and prescribed for patients with Autism Spectrum Disorder, this fact can be justified by the free access to the medicine through the Unified Health System (SUS).